Stockreport

Zenas BioPharma's Key Milestones And Market Context: Holding Through The BLA [Seeking Alpha]

Zenas BioPharma, Inc.  (ZBIO) 
PDF ZBIO's valuation is elevated, with trailing EV/sales at 86.9x, reflecting high expectations for regulatory success and commercial transition. The Phase 3 INDIGO trial [Read more]